BAVENCIO (avelumab) is a human programmed death ligand-1 (PD-L1) blocking antibody indicated in the US for locally advanced or metastatic urothelial carcinoma who have disease progression
within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy, concluded the companies.
Hence, it is best studied by correlating the comorbidities over the disease progression
using the EHR databases.
Similarly, in low-grade dysplasia, RFA upon disease progression
to high-grade dysplasia also bested the strategy of surveillance until cancer and esophagectomy, resulting in 0.
We potentially excluded a large proportion of the treatment effect and biased our population toward those with more progressive disease," yet little disease progression
was seen with combined therapy.
The authors concluded that depression is common and is an independent predictor of disease progression
and death among HIV-infected African women.
The study results suggest that greater viral genetic diversity in early HIV infection could be a mechanism by which hormonal contraception affects viral load and, ultimately, disease progression
, says Dr.
Dogs that received their own cells with corrected genes also showed slower disease progression
than did the untreated dogs but not as dramatic an improvement as did the dogs that received donor cells.
Relevant topics for study of the nonmalignant urological diseases in adults or children could include, but are not limited to 1) diagnostic tools and instruments that can asses the extent and physiological parameters of disease and evaluate disease progression
or response to therapy; 2) improved diagnostic criteria for diseases and disease subcategories; 3) accurate epidemiologic data on diseases in various ethnic and racial groups; 4) validated strategies to access early detection of disease, for disease progression
and for response to therapy; 5) novel approaches to preventing the onset of disease or preventing the progression of established disease; 6) studies of the effect of the treatment of comorbid disorders on the symptoms, progression, and morbidity of urological diseases.
Infection with HIV is the strongest known risk factor for disease progression
Chronic anxiety also appears to greatly increase disease progression
, probably through different biochemical pathways.
You have to be very careful if you have HIV and HCV because HIV can accelerate HCV disease progression
by 2 times.
A stable partnership was associated with slower disease progression
in a recent study of HIV patients receiving highly active antiretroviral therapy.